Skip to content

The prospective trial for the usefulness of hepatic vein arrival time using a microbubble contrast enhanced ultrasonography in non-invasive estimation of the severity of portal hypertension in cirrhotic patients

The usefulness of hepatic vein arrival time using a microbubble contrast enhanced ultrasonography in non-invasive estimation of the severity of portal hypertension in cirrhotic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000257
Enrollment
105
Registered
2011-11-03
Start date
2011-05-10
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The measurement of hepatic venous pressure gradient (HVPG) and Hepatic vein arrival time (HVAT) using a microbubble contrast enhanced ultrasonography (CEUS)are evaluated. In this s

Sponsors

Yonsei University, Wonju Severance Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Clinically definite liver cirrhosis patients or confirmed by liver biopsy (2) Patients who evaluate portal hypertension by hepatic vein pressure gradient (3) Patients who agree with enroll this study

Exclusion criteria

Exclusion criteria: (1) Baseline systolic blood pressure10mg/dL) (6) Serum creatinine = 1.2mg/dL (7) Past history of shunt procedure or TIPS (8) Administration of beta-blocker, ACE inhibitor, nitrate within 1month (9) Pregnancy (10) Patients who disagree with enroll this study (11) Patients who did not perform this study

Design outcomes

Primary

MeasureTime frame
The relationship between HAVT and HVPG

Secondary

MeasureTime frame
The mortality and variceal bleeding during 3years follow up;The variceal bleeding during 3years follow up

Countries

Korea, Republic of

Contacts

Public ContactMoon Kim

Yonsei University, Wonju Severance Christian Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026